Clinical beta notice

Disclaimer: These workbenches are the work of a single person, Dr. Ali Al-Ibrahim, they are all in beta and might have errors. Please report bugs, errors and improvements to Alioud16@gmail.com.

Intended use, evidence & limitations

Clarify unexpected IgM and discordant results; review pathogen-specific confirmation, fetal PCR timing, maternal treatment / exposure protection, anemia surveillance and neonatal handover across a broad perinatal-infection library.

Professional workbench in beta. Review sources, model scope and units before interpreting outputs. Software verification does not establish clinical validation.

Methods & evidence standards ↗
PERINATAL INFECTION · EVIDENCE BEFORE LABELS

Fetal Infection Workbench

Clarify the result.
Know what cannot wait.

Maternal · Fetal · NewbornClinical approval pending
Fictional teaching cases — replace current entries only after confirmation
CLINICAL ENTRY

Clinical detail. Clear priorities.

Tab moves forward; Shift+Tab returns. Enter advances text / number fields. Native select and Space keys are preserved. Ctrl / ⌘ + Enter reviews.

1 · Pregnancy & priorities0 recorded

Choose the pathogen / question first. No default infection, gestation, normal scan, immune status or treatment is assumed. Changing pathogen clears test-specific data after confirmation.

Sepsis can occur without fever. Acute dyspnea, shock, altered consciousness, significant bleeding or other deterioration requires immediate clinical assessment.
2 · Exposure & illness0 recorded

Exposure is not the same as acquisition. Enter exact dates where known, symptoms and the relevant geography / contact; do not infer an infection date from a single IgM.

Record source / dates and local public-health advice. This tool does not provide live outbreak surveillance.
3 · Antibodies & confirmation0 recorded

These controls are pathogen-specific. Unknown / not performed is not negative. Review original units, method, cutoffs and earlier stored samples with microbiology.

Record the basis, dates and what remains uncertain. A conclusion without the original evidence is not certified by the tool.
4 · Pathogen-specific results0 recorded

Use the appropriate diagnostic sequence—not generic TORCH antibodies. Result fields are cleared when the pathogen changes. Qualitative RNA status is not inferred from a blank viral-load number.

5 · Direct tests & fetal PCR0 recorded

A positive maternal test is not proof of fetal infection. Verify target, specimen, illness day, assay validation and contamination / confirmation concerns.

6 · Dating & test timing0 recorded

A planning aid, not procedural clearance. Use the latest plausible acquisition bound supported by the reviewed evidence—not the date an isolated IgM was drawn.

For preconception / uncertain dates agree a conservative bound or specialist schedule; no negative-GA extrapolation.
7 · Fetal phenotype & anemia0 recorded

Record observed findings, not expected findings for the pathogen. A normal / unassessed scan must not exclude infection or hearing / later developmental effects.

8 · Treatment & safety0 recorded

The workbench does not prescribe or certify treatment. Record the actual specialist plan, safety checks and what is pending. Drug, laboratory and national policies require local verification.

9 · Follow-up & handover0 recorded

Name the owner and due date for every pending result. Status is user-recorded—not an automatic referral, order, consent or counselling attestation.

VERIFY THE SIGNAL · PROTECT THE PREGNANCY · CLOSE THE LOOP

Start with the organism and the question

A result is the beginning of a clinical question—not the answer to all of them.

THE QUESTIONNot selectedCurrent GA Not recorded
MATERNAL EVIDENCEVerification pendingNot assessed / unknown
FETAL STATUSNot established by this toolNo IgM / scan-based fetal diagnosis
3 unresolved assessment items
  • Choose the pathogen / clinical question.
  • Original laboratory reports, identity, methods, sample context and scope have not been verified.
  • Fetal imaging is unassessed / unverified, not automatically normal.

No individual transmission, congenital-syndrome or disability percentage is calculated. Reference pathways are conditional—not automatic orders, diagnoses or consent.

No valid current case report available.

Case entries stay in page memory; no new case persistence or transmission is introduced. Reload / Reset all clears the in-memory case. Historical saved data is not loaded. Clipboard, downloaded and printed records remain under your control.

Clear this input section?

Visible and hidden fields in this section return to blank / unknown. Other sections remain; relevant source / timing acknowledgements are invalidated. The handover acknowledgement will be cleared.

An unexpected IgM: what next?

100%
Original clinical reasoning flow: an unexpected IgM result first requires the original assay, symptoms, exposure and earlier samples. Separate early infection from persistent or false reactivity using pathogen-specific reference testing; HIV, hepatitis, syphilis and HSV use different diagnostic sequences. Urgent maternal illness, exposure prophylaxis and fetal anemia proceed in parallel, not after waiting for a generic repeat TORCH panel.

Verify before labelling. A result that needs confirmation must not delay time-critical treatment or protection; nor should it trigger an irreversible decision by itself.

Original vector teaching artwork · Not a complete protocol · Clinical / illustration approval pending.

Workbench Reference & About

Version: 2.0 local review
Guideline version: ECCI / RCOG / ISUOG; pathogen-specific SMFM, CDC, NIH, WHO and AASLD–IDSA guidance
Last reviewed date: 20 October 2026
Formula source: Evidence-supported AF timing; shared anemia-workbench MCA reference; no gestational infection risk curves
Coefficient source: No invented transmission, severity, serologic PPV or ultrasound compatibility coefficients
Validation notes: Local software / browser verification; independent MFM, ID / microbiology and neonatal approval required
Known limitations: Not all infections / assays / outbreaks are covered. Maternal infection, acquisition timing, fetal infection and fetal injury are distinct. Guideline / local policy differences remain explicit. Not prescribing, procedural clearance, consent or regulatory approval.
What changed in this version: Controlled React rebuild; pathogen-specific result interpretation / confirmation; 26-infection library plus unclassified pathway; explicit timing frameworks; maternal / fetal / neonatal actions; current drafts; keyboard / reset safeguards; original teaching algorithms.
© 2026 Dr. Ali Hussein Al Ibrahim. All rights reserved.